MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5863/jppt-25-00052

Медицинская библиотека · The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026

Assessment of Enteral Baclofen Prescribing Practices for Infants With Hypertonia.

DiTaranto Hope E, Moore Astrela, Kendsersky Rebecca, Zook Jessica, Katz Elana, Evans Sarah H, King J Michael

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Baclofen is used for hypertonia in infants despite limited dosing guidance. This study describes enteral baclofen prescribing in patients 12 months of age and younger.

METHODS

This single-center, retrospective review evaluated infants receiving enteral baclofen from January 2013 to December 2022. Regimen information, including dose, frequency, age, weight, and duration of treatment for up to 1 year following initiation, was assessed. Other outcomes included place in therapy, safety, and tolerability.

RESULTS

This study included 108 patients with 423 total regimens. At initiation, the median baclofen dose was 1.3 mg, corresponding to a weight-based dose (WBD) of 0.2 mg/kg, a total daily dose (TDD) of 3 mg, and a weight-based total daily dose (wTDD) of 0.5 mg/kg/day. Sixty-one patients (56.5%) received baclofen 3 times daily at initiation. The patients' longest-tolerated regimen had a median dose of 2.8 mg, corresponding to a WBD of 0.4 mg/kg, a TDD of 9 mg, and a wTDD of 1.3 mg/kg/day. Hypoxemic-ischemic encephalopathy and brain injury were the most common etiologies of hypertonia. Baclofen was the first antispastic agent for 37 patients (34.3%). Twenty-four patients (22.2%) discontinued baclofen within 1 year. Four patients (3.7%) stopped baclofen due to adverse effects (sedation and emesis).

CONCLUSIONS

The median initiation dose of baclofen in infants was lower than the recommended dose for patients aged younger than 2 years, highlighting variability in practice. The baclofen regimens used in this study were safe and well-tolerated. These findings provide insight into baclofen prescribing for infants with hypertonia.

Для цитирования: DiTaranto Hope E, Moore Astrela, Kendsersky Rebecca, Zook Jessica, Katz Elana, Evans Sarah H, King J Michael. Assessment of Enteral Baclofen Prescribing Practices for Infants With Hypertonia.. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2026. DOI: 10.5863/jppt-25-00052.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.